Table 4.
Variable | All Controls | All Cases | ||||
---|---|---|---|---|---|---|
Patients (n) | Spearman ρ | P Value | Patients (n) | Spearman ρ | P Value | |
Total cholesterol | 147 | 0.27 | <0.001 | 65 | 0.12 | 0.35 |
Triglycerides | 147 | 0.09 | 0.28 | 65 | 0.25 | 0.04 |
LDL cholesterol | 143 | 0.20 | 0.02 | 61 | −0.05 | 0.70 |
HDL cholesterol | 146 | 0.10 | 0.21 | 63 | 0.13 | 0.32 |
C-reactive protein | 179 | 0.03 | 0.72 | 89 | 0.01 | 0.90 |
β2-Microglobulin | 179 | −0.11 | 0.14 | 89 | 0.13 | 0.24 |
sTNFR1 | 179 | −0.08 | 0.30 | 89 | 0.05 | 0.65 |
sTNFR2 | 179 | −0.17 | 0.02 | 89 | 0.00 | 1 |
IL-6 | 179 | 0.11 | 0.13 | 89 | −0.02 | 0.85 |
CCL2 | 179 | −0.06 | 0.45 | 89 | 0.06 | 0.56 |
CCL5 | 179 | 0.16 | 0.03 | 89 | 0.19 | 0.07 |
IFN-α | 179 | −0.06 | 0.40 | 89 | 0.04 | 0.74 |
Complete fasting lipid data were not available for all patients at the case definition time point (baseline) when APOL1 plasma levels were assayed. Correlation values between |0.2 and 0.39| are considered weak.